By Tom Zanki ( April 23, 2020, 3:07 PM EDT) -- Venture-backed oncology firm Oric Pharmaceuticals Inc. raised $120 million Thursday in an upsized initial public offering that priced at the top of its range, a strong sign in an otherwise tepid IPO market where activity is mostly limited to biotechnology firms....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.